期刊文献+

携带人二氢叶酸还原酶基因慢病毒表达载体构建及鉴定

Construction of a Lentiviral Expression Vector Harboring Human Dihydrofolate Reductase Gene
原文传递
导出
摘要 目的:构建携带人二氢叶酸还原酶(DHFR)基因的慢病毒表达载体pWPI。方法:采用PCR方法扩增二氢叶酸还原酶cDNA全长,与EZ-T克隆载体连接,HindIII及BamHI-HF限制性内切酶双酶切回收的PCR片段并补平其缺口。慢病毒系统载体使用pWPI系统,采用PmeI酶切载体后回收片段,将其磷酸化,T4酶连接载体与目的基因。表达载体鉴定均采用核苷酸序列测定,重组质粒采用脂质体转染293T包装细胞后获得包装的病毒颗粒。结果:成功扩增二氢叶酸还原酶全长并连接入pWPI载体构建成重组表达载体DHFR-pWPI,重组质粒测序结果显与DHFR基因的同源性达100%,按标准生产程序转染293T后有DHFR基因的表达。结论:成功采用慢病毒载体系统构建了二氢叶酸还原酶重组慢病毒转基因,为探讨DHFR在肿瘤多药耐药过程中的分子机理奠定基础。 Objective: To construct a lentiviral expressing vector harboring human Dihydrofolate reductase(DHFR)gene.Methods: The cDNA length of DHFR gene was amplified by PCR and was connected to cloned vector EZ-T,then the recovered PCR fragment was obtained by digesting with restriction enzymes named HindIII and BamHI-HF,and then blunted at the gap.Lentiviral vector system adopted pWPI system.The vector pWPI was digested with PmeI enzyme,and then it was recovered fragment and phosphorylated.The phosphorylated vector was connected with DHFR gene by T4 enzyme.Recombinant plasmid was confirmed by PCR and sequencing nucleotide.The recombinant retroviral vector pWPI was selected to transfect packaging cell 293T to gain virus particles with infection ability.Results: The recombinant plasmid,named DHFR-pWPI,which was constructed and identified Packaged by packaging cell 293T.The homology between sequencing results and DHFR gene sequence was up to 100%,and the expression of DHFR in 293T cells was determined by RT-PCR.Conclusion: The lentiviral expressing vector harboring human DHFR has been constructed successfully,which made the foundation to explore the molecular mechanism of multidrug-resistance in tumor.
出处 《现代生物医学进展》 CAS 2012年第10期1831-1836,1910,共7页 Progress in Modern Biomedicine
基金 国家自然基金资助(30960404) 研究生科研创新项目及改革和发展项目(309356)
关键词 DHFR 慢病毒载体Pwpi 293T细胞 DHFR Lentiviral expression vector 293T cell lines
  • 相关文献

参考文献15

  • 1Gershoni-Baruch R, Dagan E, Israeli D, et al. Association of the C667T polymorphism in the MTHFR gene with breast and/or ovarian cancer risk in Jewish women [J]. Eur J Cancer, 2000, 36 (18): 2313-2316.
  • 2Sierra E E, Goldman I D. Recent advances in the understanding of the mechanism of membrance transport of folates and antifolates [J]. Semin Oncol, 1999, 26(2): 11-23.
  • 3Gait J R, Halkar R K, Evans C O, et al. In vivo assay of folate receptors in nonfunctional pituitary adenomas with 99mTc-folate SPECT/CT[J]. J Nucl Med, 2010, 51(11): 1716-1723.
  • 4高海德,路平,鲁阳,庞葵,徐惠绵,王舒宝,陈峻青,赵实诚.双突变二氢叶酸还原酶基因对小鼠的化疗保护作用[J].中华肿瘤杂志,2006,28(8):583-585. 被引量:3
  • 5Schellens JH, Maliepaard M, Scheper RJ, et al. Transport of topoisomerase I inhibitors by the breast cancer resistance protein. Potential clinical implications [J]. Ann NY Acad Sci, 2000, 922: 188-194.
  • 6于明东,李书忠.实时荧光定量PCR法检测人骨肉瘤耐MTX细胞系中RFC、DHFR、GST-π的mRNA表达[J].中国矫形外科杂志,2009,17(11):858-861. 被引量:12
  • 7黄瀚,李兵,欧阳林旗,李佐军,刘世坤.叶酸受体及二氢叶酸还原酶与人乳腺癌细胞MCF-7/ADR多药耐药的关系[J].中国药理学通报,2011,27(1):99-103. 被引量:8
  • 8Askari BS, Krajinovic M. Dihydrofolate reductase gene variations in susceptibility to disease and treatment outcomes [J]. Curr Genomics, 2010,11(8): 578-583.
  • 9董改霞,洪行球,黄燕芬.基因逆转肿瘤多药耐药的研究进展[J].现代生物医学进展,2008,8(12):2367-2369. 被引量:4
  • 10Li L, Luan Y, Li X, et al. Demonstration of differential gene expression between sensitive and resistant ovarian tumor cells by fluorescence differential display-PCR analysis [J]. Oncol Rep, 2005, 13(5): 793-799.

二级参考文献30

共引文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部